Instil Bio, Inc. (TIL)
NASDAQ: TIL · IEX Real-Time Price · USD
0.414
+0.002 (0.39%)
Sep 28, 2023, 9:39 AM EDT - Market open
Instil Bio Stock Forecast
TIL's stock price has decreased by -91.37% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 stock analysts, the average 12-month stock price forecast for Instil Bio stock is $6.00, which predicts an increase of 1,349.28%. The lowest target is $2.00 and the highest is $14. On average, analysts rate Instil Bio stock as a buy.
Analyst Consensus: Buy
* Price targets were last updated on Aug 17, 2023.
Analyst Ratings
The average analyst rating for Instil Bio stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2 | Strong Buy | Reiterates | $2 | +383.09% | Aug 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $2 | Strong Buy | Initiates | $2 | +383.09% | Jun 29, 2023 |
| Truist Securities | Truist Securities | Hold Initiates $6 | Hold | Initiates | $6 | +1,349.28% | Apr 5, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $6 → $2 | Hold | Maintains | $6 → $2 | +383.09% | Dec 12, 2022 |
| Baird | Baird | Buy Maintains $24 → $14 | Buy | Maintains | $24 → $14 | +3,281.64% | Nov 17, 2022 |
Financial Forecast
Revenue This Year
673.34K
Revenue Next Year
1.52M
from 673.34K
Increased by 125.00%
EPS This Year
-0.77
from -1.72
EPS Next Year
-0.60
from -0.77
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 2.1M | 3.2M | n/a | 5.3M | 102.7M |
| Avg | 673,337 | 1.5M | n/a | 2.5M | 49.4M |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | 367.8% | - | - | 3,966.9% |
| Avg | - | 125.0% | - | - | 1,856.0% |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | -0.72 | -0.33 | -0.75 |
| Avg | -0.77 | -0.60 | -0.72 |
| Low | -0.87 | -0.72 | -0.70 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.